BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 11066053)

  • 1. Successful treatment of metastatic retinoblastoma.
    Dunkel IJ; Aledo A; Kernan NA; Kushner B; Bayer L; Gollamudi SV; Finlay JL; Abramson DH
    Cancer; 2000 Nov; 89(10):2117-21. PubMed ID: 11066053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intensive multimodality therapy for patients with stage 4a metastatic retinoblastoma.
    Dunkel IJ; Khakoo Y; Kernan NA; Gershon T; Gilheeney S; Lyden DC; Wolden SL; Orjuela M; Gardner SL; Abramson DH
    Pediatr Blood Cancer; 2010 Jul; 55(1):55-9. PubMed ID: 20486171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of metastatic retinoblastoma.
    Rodriguez-Galindo C; Wilson MW; Haik BG; Lipson MJ; Cain A; Merchant TE; Kaste S; Pratt CB
    Ophthalmology; 2003 Jun; 110(6):1237-40. PubMed ID: 12799253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-dose chemotherapy with autologous hematopoietic stem cell rescue for stage 4B retinoblastoma.
    Dunkel IJ; Chan HS; Jubran R; Chantada GL; Goldman S; Chintagumpala M; Khakoo Y; Abramson DH
    Pediatr Blood Cancer; 2010 Jul; 55(1):149-52. PubMed ID: 20486181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful treatment of metastatic retinoblastoma with high-dose chemotherapy and autologous stem cell rescue in South America.
    Palma J; Sasso DF; Dufort G; Koop K; Sampor C; Diez B; Richard L; Castillo L; Chantada GL
    Bone Marrow Transplant; 2012 Apr; 47(4):522-7. PubMed ID: 21602901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retinoblastoma CSF metastasis cured by multimodality chemotherapy without radiation.
    Dimaras H; Héon E; Budning A; Doyle JJ; Halliday W; Gallie BL; Chan HS
    Ophthalmic Genet; 2009 Sep; 30(3):121-6. PubMed ID: 19941416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trilateral retinoblastoma: potentially curable with intensive chemotherapy.
    Dunkel IJ; Jubran RF; Gururangan S; Chantada GL; Finlay JL; Goldman S; Khakoo Y; O'Brien JM; Orjuela M; Rodriguez-Galindo C; Souweidane MM; Abramson DH
    Pediatr Blood Cancer; 2010 Mar; 54(3):384-7. PubMed ID: 19908299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-dose chemotherapy with carboplatin, etoposide and cyclophosphamide followed by a haematopoietic stem cell rescue in patients with high-risk retinoblastoma: a SFOP and SFGM study.
    Namouni F; Doz F; Tanguy ML; Quintana E; Michon J; Pacquement H; Bouffet E; Gentet JC; Plantaz D; Lutz P; Vannier JP; Validire P; Neuenschwander S; Desjardins L; Zucker JM
    Eur J Cancer; 1997 Dec; 33(14):2368-75. PubMed ID: 9616283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Results of a prospective study for the treatment of unilateral retinoblastoma.
    Chantada GL; Fandiño AC; Guitter MR; Raslawski EC; Dominguez JL; Manzitti J; de Dávila MT; Zubizarreta P; Scopinaro M
    Pediatr Blood Cancer; 2010 Jul; 55(1):60-6. PubMed ID: 20486172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-dose chemotherapy with autologous stem cell rescue in children with retinoblastoma.
    Kremens B; Wieland R; Reinhard H; Neubert D; Beck JD; Klingebiel T; Bornfeld N; Havers W
    Bone Marrow Transplant; 2003 Feb; 31(4):281-4. PubMed ID: 12621463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of massive orbital involvement of intraocular retinoblastoma.
    Kiratli H; Bilgiç S; Ozerdem U
    Ophthalmology; 1998 Feb; 105(2):322-6. PubMed ID: 9479294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metastatic retinoblastoma: single institution experience over two decades.
    Cozza R; De Ioris MA; Ilari I; Devito R; Fidani P; De Sio L; Demelas F; Romanzo A; Donfrancesco A
    Br J Ophthalmol; 2009 Sep; 93(9):1163-6. PubMed ID: 19556217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multidisciplinary treatment strategy that includes high-dose chemotherapy for metastatic retinoblastoma without CNS involvement.
    Matsubara H; Makimoto A; Higa T; Kawamoto H; Sakiyama S; Hosono A; Takayama J; Takaue Y; Murayama S; Sumi M; Kaneko A; Ohira M
    Bone Marrow Transplant; 2005 Apr; 35(8):763-6. PubMed ID: 15750608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical features, treatment and prognosis of retinoblastoma in distant metastasis stage].
    Hu HM; Zhang WL; Wang YZ; Shi JT; Li B; Zhang Y; Li J; Wen Y; Huang DS
    Zhonghua Yan Ke Za Zhi; 2017 Feb; 53(2):121-127. PubMed ID: 28260363
    [No Abstract]   [Full Text] [Related]  

  • 15. Trilateral retinoblastoma: a systematic review and meta-analysis.
    de Jong MC; Kors WA; de Graaf P; Castelijns JA; Kivelä T; Moll AC
    Lancet Oncol; 2014 Sep; 15(10):1157-67. PubMed ID: 25126964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metastatic retinoblastoma clinical features, treatment, and prognosis.
    Gündüz K; Müftüoglu O; Günalp I; Unal E; Taçyildiz N
    Ophthalmology; 2006 Sep; 113(9):1558-66. PubMed ID: 16828510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-dose carboplatin, thiotepa, and etoposide with autologous stem-cell rescue for patients with recurrent medulloblastoma. Children's Cancer Group.
    Dunkel IJ; Boyett JM; Yates A; Rosenblum M; Garvin JH; Bostrom BC; Goldman S; Sender LS; Gardner SL; Li H; Allen JC; Finlay JL
    J Clin Oncol; 1998 Jan; 16(1):222-8. PubMed ID: 9440746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recurrent disseminated retinoblastoma in a 7-year-old girl treated successfully by high-dose chemotherapy and CD34-selected autologous peripheral blood stem cell transplantation.
    Hertzberg H; Kremens B; Velten I; Beck JD; Greil J
    Bone Marrow Transplant; 2001 Mar; 27(6):653-5. PubMed ID: 11319597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcome of patients with recurrent medulloblastoma or central nervous system germinoma treated with low dose continuous intravenous etoposide along with dose-intensive chemotherapy followed by autologous hematopoietic stem cell rescue.
    Grodman H; Wolfe L; Kretschmar C
    Pediatr Blood Cancer; 2009 Jul; 53(1):33-6. PubMed ID: 19326417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Potential Benefit of Three vs. Six Cycles of Carboplatin, Etoposide, and Vincristine in Postenucleation High-Risk Patients with IRSS Stage I Retinoblastoma.
    Ye H; Du Y; Chen R; Luo X; Mao Y; Ai S; Ma W; Ding Y; Li Q; Yang H
    Curr Eye Res; 2016 Nov; 41(11):1507-1512. PubMed ID: 27158739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.